Influenza A virus aH5N8c inactivated vaccine, MF59 adjuvanted (Seqirus)

N/A

Report date: 2024/05/30 20:00:07

Base Information

Drug NameInfluenza A virus aH5N8c inactivated vaccine, MF59 adjuvanted (Seqirus)
Drug Alias NameaH5N8caH5N8c
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsVirus DiseasesInfluenza, HumanRespiratory Tract Infections +[4] 
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2023/11/09
Country/TerritoryUnited StatesEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSeqirus
China Registration ClassN/A

Develop Information

Active CompaniesSeqirusSeqirus Srl
Inactive CompaniesN/A
Active IndicationsVirus DiseasesInfluenza, HumanRespiratory Tract Infections
Inactive IndicationsInfections

Other Information

ATC CodeN/A
Related LinksN/A